NCT02688088 2022-10-18A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyEli Lilly and CompanyPhase 1 Completed48 enrolled 30 charts
NCT02919696 2020-09-25A Study of Abemaciclib (LY2835219) in Native Chinese Participants With Advanced and/or Metastatic CancersEli Lilly and CompanyPhase 1 Completed26 enrolled 16 charts
NCT02117648 2019-01-07A Study of LY2835219 in Participants With CancerEli Lilly and CompanyPhase 1 Completed26 enrolled 11 charts